 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, March 9, 2005, 25(10):2504-2512; doi:10.1523/JNEUROSCI.0035-05.2005
Previous Article | Next Article
Neurobiology of Disease
The Class B Scavenger Receptor CD36 Mediates Free Radical Production and Tissue Injury in Cerebral Ischemia
Sunghee Cho,1 Eun-Mi Park,1 Maria Febbraio,2 Josef Anrather,1 Laibaik Park,1 Gianfranco Racchumi,1 Roy L. Silverstein,2 andCostantino Iadecola1 1Division of Neurobiology, 2Department of Medicine/Hematology-Oncology, Weill Medical College of Cornell University, New York, New York 10021
The class B scavenger receptor CD36 is involved in the cytotoxicity associated with inflammation, but its role in the inflammatory reaction that accompanies cerebral ischemia has not been examined. In this study, we investigated whether CD36 contributes to the brain damage produced by cerebral ischemia. The middle cerebral artery was transiently occluded in wild-type mice and in mice deficient in CD36. In wild-type mice, CD36 protein expression was increased in the ischemic brain, such that it was located predominantly in cells expressing the microglia/macrophage marker CD11b. The infarct produced by middle cerebral artery occlusion was 49% smaller in CD36-null mice than in wild-type controls, an effect associated with improved neurological function. The attenuation in brain injury in CD36 nulls could not be attributed to differences in cerebral blood flow during ischemia-reperfusion. However, the increase in reactive oxygen species (ROS) produced by cerebral ischemia was markedly attenuated in CD36-null mice in the early stage after reperfusion. The data unveil a previously unrecognized role of CD36 in ischemia-induced ROS production and brain injury. Modulation of CD36 signaling may provide a new strategy for the treatment of ischemic stroke.
Key words: CD36-null mice; stroke; inflammation; cerebral blood flow; hydroethidine; laser Doppler
Received Jan 5, 2005; revised January 25, 2005; accepted January 25, 2005.
This article has been cited by other articles:
D. Harb, K. Bujold, M. Febbraio, M. G. Sirois, H. Ong, and S. Marleau
The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation
Cardiovasc Res, July 1, 2009; 83(1): 42 - 51.
[Abstract] [Full Text] [PDF]
R. L. Silverstein and M. Febbraio
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Sci. Signal., May 26, 2009; 2(72): re3 - re3.
[Abstract] [Full Text] [PDF]
B. R. Tambuyzer, P. Ponsaerts, and E. J. Nouwen
Microglia: gatekeepers of central nervous system immunology
J. Leukoc. Biol., March 1, 2009; 85(3): 352 - 370.
[Abstract] [Full Text] [PDF]
D. M. Okamura, S. Pennathur, K. Pasichnyk, J. M. Lopez-Guisa, S. Collins, M. Febbraio, J. Heinecke, and A. A. Eddy
CD36 Regulates Oxidative Stress and Inflammation in Hypercholesterolemic CKD
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 495 - 505.
[Abstract] [Full Text] [PDF]
S. Muhammad, W. Barakat, S. Stoyanov, S. Murikinati, H. Yang, K. J. Tracey, M. Bendszus, G. Rossetti, P. P. Nawroth, A. Bierhaus, et al.
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
J. Neurosci., November 12, 2008; 28(46): 12023 - 12031.
[Abstract] [Full Text] [PDF]
E. Kim, A. T. Tolhurst, L. Y. Qin, X.-Y. Chen, M. Febbraio, and S. Cho
CD36/Fatty Acid Translocase, An Inflammatory Mediator, Is Involved in Hyperlipidemia-Induced Exacerbation in Ischemic Brain Injury
J. Neurosci., April 30, 2008; 28(18): 4661 - 4670.
[Abstract] [Full Text] [PDF]
S. Kuchibhotla, D. Vanegas, D. J. Kennedy, E. Guy, G. Nimako, R. E. Morton, and M. Febbraio
Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II
Cardiovasc Res, April 1, 2008; 78(1): 185 - 196.
[Abstract] [Full Text] [PDF]
A. Kunz, T. Abe, K. Hochrainer, M. Shimamura, J. Anrather, G. Racchumi, P. Zhou, and C. Iadecola
Nuclear Factor-{kappa}B Activation and Postischemic Inflammation Are Suppressed in CD36-Null Mice after Middle Cerebral Artery Occlusion
J. Neurosci., February 13, 2008; 28(7): 1649 - 1658.
[Abstract] [Full Text] [PDF]
C. Yang, B. R. Mwaikambo, T. Zhu, C. Gagnon, J. Lafleur, S. Seshadri, P. Lachapelle, J.-C. Lavoie, S. Chemtob, and P. Hardy
Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R467 - R476.
[Abstract] [Full Text] [PDF]
H. Aleyasin, M. W. C. Rousseaux, M. Phillips, R. H. Kim, R. J. Bland, S. Callaghan, R. S. Slack, M. J. During, T. W. Mak, and D. S. Park
The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage
PNAS, November 20, 2007; 104(47): 18748 - 18753.
[Abstract] [Full Text] [PDF]
A. Kunz, L. Park, T. Abe, E. F. Gallo, J. Anrather, P. Zhou, and C. Iadecola
Neurovascular Protection by Ischemic Tolerance: Role of Nitric Oxide and Reactive Oxygen Species
J. Neurosci., July 4, 2007; 27(27): 7083 - 7093.
[Abstract] [Full Text] [PDF]
R. O'Lone, K. Knorr, I. Z. Jaffe, M. E. Schaffer, P. G. V. Martini, R. H. Karas, J. Bienkowska, M. E. Mendelsohn, and U. Hansen
Estrogen Receptors {alpha} and {beta} Mediate Distinct Pathways of Vascular Gene Expression, Including Genes Involved in Mitochondrial Electron Transport and Generation of Reactive Oxygen Species
Mol. Endocrinol., June 1, 2007; 21(6): 1281 - 1296.
[Abstract] [Full Text] [PDF]
S. Cho, H. H. Szeto, E. Kim, H. Kim, A. T. Tolhurst, and J. T. Pinto
A Novel Cell-permeable Antioxidant Peptide, SS31, Attenuates Ischemic Brain Injury by Down-regulating CD36
J. Biol. Chem., February 16, 2007; 282(7): 4634 - 4642.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|